What do stakeholders expect from patient engagement: Are these expectations being met?

ABSTRACT:

Background

Meaningful patient engagement (PE) in medicines development and during the life cycle of a product requires all stakeholders have a clear understanding of respective expectations.

Objective

A qualitative survey was undertaken to understand stakeholder expectations.

Design

The survey explored 4 themes from the perspective of each stakeholder group: meaning, views, expectations and priorities for PE. Participants were grouped into 7 categories: policymakers/regulators; health-care professionals (HCPs); research funders; payers/purchasers/HTA; patients/patient representatives; pharmaceutical/life sciences industry; and academic researchers.

Results

Fifty-nine interviews were conducted across a range of geographies, PE experience and job seniority/role.

SUBMITTER: Boudes M 

PROVIDER: S-EPMC6250871 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature